BoneKEy-Osteovision | Perspective
New agents for the treatment of osteoporosis
T John Martin
Kong Wah Ng
Discoveries in bone biology are directing early efforts to find new drugs for the treatment of osteoporosis. For anti-resorptive therapy, much current attention is aimed at inhibiting osteoclast activity, in some cases even doing so without inhibiting bone formation as a coupled response. Human and mouse genetics have provided fascinating possibilities for new anabolic agents by identifying the activated Wnt signaling pathway as a key process in the regulation of osteoblast differentiation and bone formation.
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.